McMeekin DS - Search Results

1

Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.

Landrum LM, Moore KN, Myers TK, Lanneau GS Jr, McMeekin DS, Walker JL, Gold MA. Landrum LM, et al. Among authors: mcmeekin ds. Gynecol Oncol. 2009 Feb;112(2):337-41. doi: 10.1016/j.ygyno.2008.10.009. Epub 2008 Nov 28. Gynecol Oncol. 2009. PMID: 19041126

2

Laparoscopic pelvic and paraaortic lymph node dissection in the obese.

Scribner DR Jr, Walker JL, Johnson GA, McMeekin DS, Gold MA, Mannel RS. Scribner DR Jr, et al. Among authors: mcmeekin ds. Gynecol Oncol. 2002 Mar;84(3):426-30. doi: 10.1006/gyno.2001.6548. Gynecol Oncol. 2002. PMID: 11855882

3

Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply?

Kamelle SA, Rutledge TL, Tillmanns TD, Gould NS, Cohn DE, Wright J, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS. Kamelle SA, et al. Among authors: mcmeekin ds. Gynecol Oncol. 2004 Aug;94(2):249-55. doi: 10.1016/j.ygyno.2004.05.038. Gynecol Oncol. 2004. PMID: 15297159

4

A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?

Rutledge TL, Kamelle SA, Tillmanns TD, Gould NS, Wright JD, Cohn DE, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS. Rutledge TL, et al. Among authors: mcmeekin ds. Gynecol Oncol. 2004 Oct;95(1):70-6. doi: 10.1016/j.ygyno.2004.07.027. Gynecol Oncol. 2004. PMID: 15385112

5

Timing isn't everything: an analysis of when to start salvage chemotherapy in ovarian cancer.

McMeekin DS, Tillmanns T, Chaudry T, Gold M, Johnson G, Walker J, Mannel R. McMeekin DS, et al. Gynecol Oncol. 2004 Oct;95(1):157-64. doi: 10.1016/j.ygyno.2004.07.008. Gynecol Oncol. 2004. PMID: 15385126

6

Carcinosarcoma of the ovary-a case series.

Rutledge TL, Gold MA, McMeekin DS, Huh WK, Powell MA, Lewin SN, Mutch DG, Johnson GA, Walker JL, Mannel RS. Rutledge TL, et al. Among authors: mcmeekin ds. Gynecol Oncol. 2006 Jan;100(1):128-32. doi: 10.1016/j.ygyno.2005.07.119. Epub 2005 Oct 5. Gynecol Oncol. 2006. PMID: 16213011

7

Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era.

Landrum LM, Lanneau GS, Skaggs VJ, Gould N, Walker JL, McMeekin DS, Gold MA. Landrum LM, et al. Among authors: mcmeekin ds. Gynecol Oncol. 2007 Sep;106(3):521-5. doi: 10.1016/j.ygyno.2007.04.029. Epub 2007 May 31. Gynecol Oncol. 2007. PMID: 17540438

8

Vesicovaginal fistula formation in patients with Stage IVA cervical carcinoma.

Moore KN, Gold MA, McMeekin DS, Zorn KK. Moore KN, et al. Among authors: mcmeekin ds. Gynecol Oncol. 2007 Sep;106(3):498-501. doi: 10.1016/j.ygyno.2007.04.030. Epub 2007 Jun 11. Gynecol Oncol. 2007. PMID: 17561235

9

Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation.

Landrum LM, Skaggs V, Gould N, Walker JL, McMeekin DS. Landrum LM, et al. Among authors: mcmeekin ds. Gynecol Oncol. 2008 Mar;108(3):584-90. doi: 10.1016/j.ygyno.2007.11.010. Epub 2007 Dec 26. Gynecol Oncol. 2008. PMID: 18155755

10

Extraperitoneal para-aortic lymph node evaluation for cervical cancer via pfannenstiel incision: technique and peri-operative outcomes.

Moore KN, Gold MA, McMeekin DS, Walker JL, Rutledge T, Zorn KK. Moore KN, et al. Among authors: mcmeekin ds. Gynecol Oncol. 2008 Mar;108(3):466-71. doi: 10.1016/j.ygyno.2007.11.043. Epub 2008 Jan 14. Gynecol Oncol. 2008. PMID: 18191994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page